Medical team

Dr. med. Yasemin Alberti, M. Sc.

Specialist in Radiation Oncology

Areas of expertise

  • Sarcomas
  • Ear, Nose and Throat
  • Gastrointestinal tract

Languages

German, Turkish, English

Education

2024

Doctorate in Medicine (Dr. med.), Charité, Berlin
Topic: The Role of Radiotherapy in Intracranial and Extracranial Fibrous Tumors

2012

Board Certification in Radiation Oncology

2012

Medical License to Practice Medicine in Germany

2003 – 2004

Master’s Degree in Radiobiology, University College London, United Kingdom
Degree: Master of Science in Radiobiology

1990 – 1998

Medical Studies, University of Istanbul, Turkey
Degree: Diploma (MD)

Professional career

2021 – 2026

Senior Physician in Radiation Oncology, Department of Radiation Oncology, University Hospital Essen

2021

Specialist in Radiation Oncology, Department of Radiation Oncology and Radiotherapy, Charité – University Medicine Berlin, Campus Virchow-Klinikum

2012 – 2020

Specialist in Radiation Oncology, MVZ Radiation Therapy at Vivantes Hospital Neukölln and Spandau Hospital, Berlin

2006 – 2011

Medical positions at various university radiation oncology centers, including Leipzig University Hospital, MVZ Hamburg-Eppendorf, and Charité – Universitätsmedizin Berlin

2004 – 2006

Scientific Position, Department of Radiation Oncology and Radiotherapy, Faculty of Medicine Carl Gustav Carus, TU Dresden

2000-2003

Specialist Training in Radiation Oncology, Oncology Institute, Department of Radiation Oncology, Istanbul University, Turkey

1998 – 2000

Medical Position, Marmara General Medicine Clinic, Istanbul, Turkey

Memberships

Austrian Society for Radiation Oncology (ÖGRO)

German Society for Radiation Oncology (DEGRO) )

European Society for Radiotherapy and Oncology (ESTRO)

Working Group for Gynecological Oncology (AGO)

Turkish Society of Radiation Oncology (TROD)

Selected publications

2026

Guberina N, Khouya A, Hoffmann C, Alberti Y, et al. Do AI-based contouring algorithms
influence physicians in the online adaptive radiotherapy of patients with bladder
cancer? Radiation Oncology 2026, DOI:10.1016/j.tipsro.2026.100401

2025

Guberina N, M. Guberina, Y.Alberti, M. Stuschke.Definitive Radiochemotherapie des
Ösophaguskarzinoms: etablierte Therapie und neue Standards. Die Onkologie (2025) 31(3)
DOI:10.1007/s00761-024-01645-5

2024

Roohani S, Alberti Y, Mirwald M, Ehret F. Meningeal Solitary Fibrous Tumor: A Single-
Center Retrospective Cohort Study. Sarcoma. 2024:1-6 DOI:10.1155/2024/8846018

2023

Guberina M, Santiago Garcia A, Khouya A, Pöttgen C, Holubjev K, Ringbaek,
TK, Lachmuth M, Alberti Y, et al. Comparison of Online-Onboard Adaptive Intensity-
Modulated Radiation Therapy or Volumetric-Modulated Arc Radiotherapy with Image-
Guided Radiotherapy for Patients with Gynecologic Tumors in Dependence on Fractionation
and the Planning Target Volume Margin. JAMA Network Open. 2023;6(3).

2009

Tribius S, Kronemann S, Kilic Y, et al. Radiochemotherapy including cisplatin alone versus
cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell
carcinoma of the head and neck. Strahlenther Onkol. 2009;185(10).

2007

Kilic Y, Rajewski K, Dörr W. Effect of post-exposure administration of keratinocyte growth
factor (Palifermin) on radiation effects in oral mucosa in mice. Radiat Environ Biophys.
2007; 46:13–19.

Publications partly under the maiden name Yasemin Kilic/Kılıç.

Kontaktieren Sie uns

Sie haben Fragen zur Ionentherapie oder MedAustron?

Sie haben Fragen zur Therapie oder Ablauf? Was auch immer Sie wissen wollen, zögern Sie nicht uns zu kontaktieren. Wir melden uns binnen zwei Werktagen bei Ihnen.

Kontakt Therapieanfrage
Sie haben Fragen zur Ionentherapie oder MedAustron?